Radcliffe Capital Management’s Prenetics Global Ltd Warrant PRENW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-553,324
Closed -$4.57K 46
2024
Q1
$4.57K Sell
553,324
-98,742
-15% -$790 ﹤0.01% 73
2023
Q4
$5.31K Sell
652,066
-15,950
-2% -$241 ﹤0.01% 146
2023
Q3
$31.3K Sell
668,016
-158,273
-19% -$9.26K ﹤0.01% 229
2023
Q2
$55.2K Hold
826,289
﹤0.01% 253
2023
Q1
$72.3K Hold
826,289
﹤0.01% 308
2022
Q4
$1.65M Hold
826,289
0.05% 532
2022
Q3
$3.12M Hold
826,289
0.08% 442
2022
Q2
$3.34M Buy
+826,289
New +$308K 0.08% 451

Other funds holding PRENW

Radcliffe Capital Management's PRENW Position: Q2 2024 in Review

Radcliffe Capital Management sold out of Prenetics Global Ltd Warrant (PRENW) in Q2 2024, closing a stake of 553,324 shares — an estimated $4.57K sold.

Radcliffe Capital Management first reported a position in PRENW in Q2 2022 and held it in 8 quarters. The position peaked at $3.34M in Q2 2022. 21 funds tracked by Wall St. Rank hold PRENW as of Q2 2024.

  • Radcliffe Capital Management reported no remaining Prenetics Global Ltd Warrant position as of Q2 2024 after selling out during the quarter.
  • Radcliffe Capital Management sold 553,324 Prenetics Global Ltd Warrant shares in Q2 2024, an estimated $4.57K.
  • Radcliffe Capital Management first reported a position in Prenetics Global Ltd Warrant in Q2 2022 and held it in 8 quarters.
  • Radcliffe Capital Management's Prenetics Global Ltd Warrant position peaked at $3.34M in Q2 2022.
  • 21 funds tracked by Wall St. Rank held Prenetics Global Ltd Warrant as of Q2 2024.

Based on Radcliffe Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.